MedPath

Efficacy and safety of 1.5% and 1% pilocarpine eyedrop combined with 0.1% brimonidine compared to 1.25% pilocarpine eyedrop in presbyopia treatment

Completed
Conditions
Efficacy and safety of 1.5% and 1% pilocarpine eyedrop combined with 0.1% brimonidine compared to 1.25% pilocarpine eyedrop in presbyopia treatment
Pilocarpine, Brimonidine, presbyopia treatment
Registration Number
TCTR20220930004
Lead Sponsor
Faculty of Medicine Siriraj Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria

1) Age 40-60 years with VA least 6/6 in both eyes
2) Measured by autorefractor +/- 0.5 D and astigmatism does not exceed 0.5 D
3) Presbyopia Diagnosed by reading Rosenbaum Near VA at 14 inches, not J1+

Exclusion Criteria

1) Astigmatism more than 0.5 D
2) History of glaucoma, cataract, retinal detachment or other eye diseases obscuring vision
3) Taking medications such as psychiatric drugs, anticholinergic drugs or other drugs

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ncorrected distance visual acuity (UDVA) at visit 1,2,3,4,5,6 ETDRS chart at 4 m.
Secondary Outcome Measures
NameTimeMethod
ncorrected near visual acuity (UNVA) at visit 1,2,3,4,5,6 Rosenbaum Near chart at 14 inch
© Copyright 2025. All Rights Reserved by MedPath